News Sebela Pharmaceuticals Reports Topline P-III (TRIUMpH) Program Data of Tegoprazan for Gastroesophageal Reflux Disease (GERD)ByRidhi RastogiApril 24, 20250Comments
News Mosaic Therapeutics In-Licenses ASTX029 & ASTX295 from Astex Pharmaceuticals for Combination Therapy Development for OncologyByRidhi RastogiApril 24, 20250Comments
THOUGHTSPOT Personalized Medicine: A Paradigm Shift in Modern Treatment ApproachBySaurabh ChaubeyApril 23, 20250Comments
News Merck’s Keytruda Regimen Receives Health Canada’s Approval for Malignant Pleural Mesothelioma (MPM)ByRidhi RastogiApril 23, 20250Comments
News Boehringer Ingelheim Enters a ~$573M Deal with Tessellate Bio to Develop Novel Therapies for ALT-positive tumorsByRidhi RastogiApril 23, 20250Comments
News VERAXA Biotech Enters a Business Combination Agreement with Voyager Acquisition Corp to Develop Cancer TherapiesByRidhi RastogiApril 23, 20250Comments
News Veravas Launches VeraBIND Tau to Detect Alzheimer’s Disease & other TauopathiesByRidhi RastogiApril 23, 20250Comments
News BMS Reports Topline P-III (ARISE) Trial Data of Cobenfy as an Adjunctive Therapy for SchizophreniaByRidhi RastogiApril 23, 20250Comments
News Regeneron Enters a ~$3B Multi-Year Manufacturing Agreement with FUJIFILM Diosynth BiotechnologiesByRidhi RastogiApril 23, 20250Comments
